1 - 15 of 42 Results Clear All
Armed with a $26.5-million grant, a multi-institution collaboratory will tackle HIV in a new way
Grants News Release HIV/AIDS Virology Ott Lab CRISPR/Gene Editing
Gladstone researchers discover how to reverse cardiac scarring—and how this could treat heart failure
News Release Research (Publication) Heart Failure Cardiovascular Disease Srivastava Lab CRISPR/Gene Editing
A new human organoid developed by Gladstone scientists mimics one of the key steps in early embryonic development
News Release Research (Publication) Cardiovascular Disease McDevitt Lab CRISPR/Gene Editing Stem Cells/iPSCs
Gladstone researchers fine-tuned CRISPR-Cas9 genome editing to work on human immune cells called monocytes
News Release Research (Publication) Data Science and Biotechnology Genomic Immunology Krogan Lab Marson Lab CRISPR/Gene Editing
San Francisco Business Times—Senior Investigator Melanie Ott, MD, PhD, and Graduate Student Parinaz Fozouni explain how the CRISPR- and smartphone-based diagnostic platform they recently developed with UC Berkeley Dan Fletcher, PhD, and Nobel Laureate Jennifer Doudna, PhD, could allow low-cost and widespread testing and help to quickly curb the course of this and future pandemics.
COVID-19 Virology Doudna Lab Ott Lab CRISPR/Gene Editing
A Gladstone discovery could be selected as the top innovation in biomedicine
Awards COVID-19 Doudna Lab Krogan Lab Ott Lab CRISPR/Gene Editing
Gladstone President Deepak Srivastava moderated a conversation with Jennifer Doudna and Shinya Yamanaka.
Philanthropy Doudna Lab Yamanaka Lab CRISPR/Gene Editing Stem Cells/iPSCs
ABC7 News—Gladstone Institute of Virology Director Melanie Ott, MD, PhD, and Graduate Student Parinaz Fozouni comment on the COVID-19 detection test they recently developed with Nobel Laureate Jennifer Doudna, PhD, and UC Berkeley Professor Dan Fletcher, PhD, using CRISPR and smartphone technology.
Gladstone Experts COVID-19 Virology Doudna Lab Ott Lab CRISPR/Gene Editing
A drug candidate found by Gladstone researchers could help prevent tens of thousands of heart surgeries every year
News Release Research (Publication) Heart Failure Cardiovascular Disease Srivastava Lab AI CRISPR/Gene Editing Disease Models Stem Cells/iPSCs
The rapid, one-step mobile test could help combat the pandemic and fully reopen communities
News Release COVID-19 Data Science and Biotechnology Virology Doudna Lab Ott Lab CRISPR/Gene Editing
Nature—Melanie Ott, MD, PhD, director of the Gladstone Institute of Virology, explains how the CRISPR-based coronavirus test she recently developed with Nobel Laureate and Senior Investigator Jennifer Doudna, PhD, measures up against conventional, PCR-based tests.
Gladstone Experts COVID-19 Virology Doudna Lab Ott Lab CRISPR/Gene Editing
USA Today—Senior Investigator and Nobel Laureate Jennifer Doudna, PhD, shares her view of CRISPR-based coronavirus detection kits and the possibility they might be deployed during the current pandemic. She and Senior Investigator Melanie Ott, MD, PhD, recently described the test they developed together in a publication posted on the electronic preprint platform bioRxiv.
Gladstone Experts COVID-19 Data Science and Biotechnology Virology Doudna Lab Ott Lab CRISPR/Gene Editing
Doudna’s discovery of the CRISPR-Cas9 system revolutionized biomedical research
Awards News Release Data Science and Biotechnology Virology Doudna Lab CRISPR/Gene Editing
San Francisco Business Times—As Scribe Therapeutics Inc., the latest company founded by Senior Investigator Jennifer Doudna, PhD, announced that it landed a deal with Biogen Inc., Gladstone President Deepak Srivastava, MD, commented on the importance of CRISPR-based biotech companies for medicine and agriculture and on Doudna’s drive as a scientist.
Gladstone Experts Cardiovascular Disease Data Science and Biotechnology Doudna Lab Srivastava Lab CRISPR/Gene Editing
Life Science—The online science news hub Life Sciences highlights recent work from Senior Investigators Melanie Ott, MD, PhD, and Nevan Krogan, PhD, and their colleagues at BioHub and Synthego Corporation. The work describes the identification of host factors common to three coronaviruses including SARS-CoV-2, and could help bootstrap efforts to stem current and future coronavirus epidemics.
Gladstone Experts COVID-19 Data Science and Biotechnology Virology Krogan Lab Ott Lab CRISPR/Gene Editing
